+44 (0)115 787 0175 enquiry@upperton.com

About Upperton

Experts in spray drying and formulation development

Founded in 1999, Upperton Pharma Solutions have a long track record in overcoming complex formulation challenges, and taking products from early feasibility batches to Phase II and beyond.

Our primary focus has always been on the versatile technology of spray drying and we have built up the expertise to support even the most challenging of molecules.

From our R&D labs and pilot plant facility in BioCity Nottingham, our experienced team of scientists work to deliver spray drying and formulation development services, to pharmaceutical and biotech companies throughout the world.

Our services include:

  • A comprehensive spray drying service: From bench top production of milligram-scale feasibility batches to kilogram-scale production in our pilot plant
  • Full pharmaceutical development service: Including pre-formulation screening formulation and final dosage form development.
  • Extensive physical and chemical characterisation of in-process and finished products
  • cGMP spray drying and clinical dosage for manufacture and associated regulatory/analytical support
  • Richard Johnson

    Richard Johnson

    Founder and CEO

    With more than 30 years of experience in Pharmaceutical and Biotechnology industry, Dr Johnson has held various senior R&D positions in both the pharmaceutical and biotechnology industry. Dr Johnson has a proven track record in innovative pharmaceutical research and clinical development. This knowledge has been used to direct the successful development of a number of pharmaceutical products from early research to commercial manufacture.

  • Karen Coombes

    Karen Coombes

    Operations Director

    With more than 20 years of experience in the pharmaceutical/biotechnology industry, Ms Coombes has worked with research teams in a number of pharmaceutical/biotechnology research institutions, including Advanced Protein Systems, Andaris Limited (Vectura) and Unilever Research. In 2008 Ms Coombes joined Upperton as Operations Director and is responsible for the company's scale up and clinical trials manufacturing activities.

  • Mark Bird

    Mark Bird

    IT Manager

  • Andrew Naylor

    Andrew Naylor

    R&D Director

    Dr Naylor was appointed as R&D Director for Upperton Ltd in August 2015. Dr Naylor is responsible for directing all of our research and development activities. Before joining Upperton Dr Naylor worked for Critial Pharmaceuticals for 9 years as Head of Process Development and he successfully managed several of the company's drug development projects. Dr Naylor currently sits on several Royal Society of Chemistry special interest group committees in the fields of polymer and materials science.

  • Laura Mason

    Laura Mason

    Senior Scientist

  • Shailesh Mistry

    Shailesh Mistry

    Senior Scientist

  • Mark Kuzniar

    Mark Kuzniar

    Scientific & Engineering Technical Manager

  • Matt Chillman

    Matt Chillman

    Process Scientist

  • Kirk Jeffery

    Kirk Jeffery

    Project Scientist

  • Nicholas Arrowsmith

    Nicholas Arrowsmith

    Project Scientist

  • Jack Sorrell

    Jack Sorrell

    Project Scientist

  • Iona Munro

    Iona Munro

    Project Scientist

  • Faye Henderson

    Faye Henderson

    Admin and HR Office Manager

  • Richard Johnson
  • Karen Coombes
  • Mark Bird
  • Andrew Naylor
  • Laura Mason
  • Shailesh Mistry
  • Mark Kuzniar
  • Matt Chillman
  • Kirk Jeffery
  • Nicholas Arrowsmith
  • Jack Sorrell
  • Iona Munro
  • Faye Henderson

About Us

With over 20 years of experience we have successfully spray dried, formulated and characterised a vast range of pharmaceutical and biotechnology products for companies across the globe.

MORE DETAILS

Contact Us

Would you like to find out more about our services or how we can help advance your project?

MORE DETAILS

Latest News

- Address

Upperton Ltd
BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF

- Contact
+44 (0)115 787 0175
enquiry@upperton.com